To seek whether JMJD8 can predict therapeutic responses to cancers, we obtained the data from ROCplotter to show the association between the therapeutic outcomes and JMJD8 expression in four cancer types (BRCA, OV, GBM, and CRC). This evidence concerns the gene JMJD8 and colorectal carcinoma.